ArticleCancer research2018

miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the

Tianxiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.